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Abstract: Gastro-Oesophageal Reflux (GOR) has been associated with chronic airway diseases while the passage of foreign matter
into airways and lungs through aspiration has the potential to initiate a wide spectrum of pulmonary disorders. The clinical syndrome
resulting from such aspiration will depend both on the quantity and nature of the aspirate as well as the individual host response.
Aspiration of gastric fluids may cause damage to airway epithelium, not only because acidity is toxic to bronchial epithelial cells but
also due to the effect of digestive enzymes such as pepsin and bile salts. Experimental models have shown that direct instillation of
these factors to airways epithelia cause damage with a consequential inflammatory response. The pathophysiology of these responses
is gradually being dissected, with better understanding of acute gastric aspiration injury, a major cause of acute lung injury, providing
opportunities for therapeutic intervention and potentially,  ultimately,  improved understanding of the chronic airway response to
aspiration. Ultimately, clarification of the inflammatory pathways which are related to micro-aspiration via pepsin and bile acid salts
may eventually progress to pharmacological intervention and surgical studies to assess the clinical benefits of such therapies in
driving symptom improvement or reducing disease progression.
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1. BACKGROUND
Gastro-Oesophageal Reflux Disease (GORD) affects approximately 20% of the population of the western world [1].
The possible relationship between GORD and airways disorders has long been postulated. While physicians generally
acknowledge  a  link  between  oesophageal  disorders  and  respiratory  disease,  this  relationship  is  complex  and  may
manifest in a variety of clinical ways. In particular, Gastro-Oesophageal Reflux (GOR) seems to be frequently present
in patients with advanced lung diseases [2].
Gastro-oesophageal  reflux  is  caused  by  stomach  contents  leaking  into  the  oesophagus,  which  in  turn  has  the
potential to lead to aspiration of these contents into the adjoining respiratory tract. In healthy subjects, the amount of
aspirated material is usually small and can be cleared by host defense mechanisms without consequence. However, if
aspiration is to result in adverse clinical consequences, the nature of the evolving illness will be dependent on the nature
and volume of the aspirated material, the temporal nature of the insult, and the elicited host responses [3]. Aspiration of
large amounts of gastric acid will result in the induction of a chemical injury to the airways and lung parenchyma. The
initial insult triggers a cascade of inflammatory responses with the recruitment of inflammatory cells and the release of
various inflammatory mediators [4]. Large volume gastric acid aspiration may cause an acute lung injury, with diffuse
alveolar damage and pneumonitis. In contrast, recurrent small volume aspiration during sleep appear may be without
consequence  or  result  in  chronic  and  less  severe  forms  of  lung  injury  [3].  Damage  to  the  airway  epithelium  from
aspiration of gastric fluids may be due to the toxicity of its low pH, (with Song et al. having previously demonstrated
normal airway pH to be 7.3 independent of airway size) [5]. In vivo and in vitro models  have  examined  the  effect of
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acid aspiration on lung injury and inflammation, using hydrochloric acid, with a pH ranging from 1 to 1.5. Davidson et
al. crucially demonstrated that gastric particles (both acidified and non-acidified) were also found to contribute to lung
injury [6]. It had previously been shown that neutrophil influx into the lungs is mediated via an interleukin-6 (IL-6) and
IL-8 pathway with Sacco et al. demonstrating a relationship between acidity and aspiration, increased IL-8 levels and
airway neutrophil counts in asthmatic patients [7].
In those individuals who aspirate, recurrent respiratory tract infections are a common consequence, with the ensuing
development  of  bronchiectasis  a  possible  end-stage  manifestation.  Normal  inflammatory  responses  to  infection
exhibited by macrophages are blunted due to weakly acidic conditions [8]. In the Cystic Fibrosis (CF) pig model, loss
of antimicrobial peptide activity causes a reduction in bacterial killing, as a direct consequence of a reduction in airway
surface liquid pH [9]. Epithelial regulation of local immunity through secretion of chemoattractants such as IL-8 in
response to infection has been postulated with Hackett et al. showing that a weakly acidic environment might blunt this
response [10]. In a cohort of patients prone to micro-aspiration they investigated whether or not lipopolysaccharides
(LPS)-induced expression of inflammatory/chemotactic proteins was modulated by an acidic environment [11]. In cells
exposed  for  4  hours  at  weakly  acidic  pH,  LPS-induced  cytokine  expression  was  reduced.  Expression  was  further
reduced on 16 hours  exposure  to  low pH,  but  this  time a  significant  decrease  in  cell  viability  was  also  noted.  The
authors subsequently observed a significant reduction in LPS-induced cytokine production following weakly acidic
shock treatment and subsequent prolonged exposure to endotoxin at normal pH, in turn potentially compromising the
response to infection through the reduction in cytokine production and the potential for subsequent diminished immune
cell recruitment.
Recent research has shown that microbiological growth from gastric juice occurred when gastric juice pH was >4
and that the gastric and airway microbiome compositions of people with CF who reflux are similar in profile. This
novel data suggests the existence of an aero-digestive microbiome in CF, which may ultimately have clinical relevance.
This host response to aspiration as well as its potential to induce changes in the pulmonary microbiome needs further
investigation, with its importance only gradually gaining widespread recognition [12 - 14].
2. PEPSIN AND BILE ACIDS
The acidity of gastric fluids might not be the only potential mechanism of airways damage and a pro-inflammatory
response to aspiration. It is possible that digestive enzymes such as pepsin and Bile Acids (BA) may also play roles as
mediators of this airway response to aspiration injury.
Pepsin is  stored as  inactive pepsinogen in  the chief  cells  of  the gastric  mucosa.  It  is  a  protease involved in  the
digestion  of  food,  and its  activity  is  acid-dependent.  The conversion of  pepsinogen to  pepsin  in  the  stomach starts
slowly at pH 6 and reaches optimal activity between pH 1.5 to 2.5. Above pH 6.8, pepsin becomes inactive and above
pH 7.5 it is fully inactive and irreversibly denatured [15]. In human gastric fluid, the pH ranges from 1.5 to 3, which
allows optimal pepsin activity, and the concentration of pepsin varies from 0.5 to 1 mg/ml [16].
In recent years, there has been an increasing acceptance of measured pepsin within the airways as representing an
important and reliable biomarker for gastric aspiration [17 - 19]. Detectable airway pepsin has been associated with
broncho-pulmonary  dysplasia  in  children  and  with  post  lung  transplant  allograft  rejection  [20,  21].  Clinical  and
scientific experimental studies are needed to delineate whether pepsin is solely a marker of aspiration, or whether these
associations are in part due to the pathological actions of pepsin. Amplification of cell and tissue damage may be a
result of the combined breakdown of protein by pepsin and independent acid damage. In oesophageal tissue of rabbits,
increased  tissue  damage has  been  demonstrated  with  exposure  to  pepsin  in  acid  as  compared  to  the  tissue  damage
caused by the action of acid administered in isolation [22]. The cytotoxicity and inflammation caused by a combination
of acid and pepsin on airway epithelium has, to date not been fully defined.
Utilizing  a  bronchial  epithelial  cell  model,  Bathoorn  et  al.  found  pepsin  to  be  both  cytotoxic  and  to  induce  an
inflammatory response in cells [23]. Pepsin-induced cytotoxicity to human bronchial epithelial (16HBE) cells is pH-
dependent,  with  the  greatest  effect  seen  at  the  lowest  acidity.  Similarly,  pepsin-mediated  IL-6  and  IL-8  release  is
optimized  through  lowering  the  pH  of  the  media.  In  vivo  studies  have  found  that  erosive  lesions  in  esophageal
epithelium exposed to pepsin are caused by the destruction of junctional molecules, with similar lesions described in the
airways following gastric fluid aspiration [22].
Gastro-oesophageal reflux-derived bile acids have been detected in the Bronchoalveolar Lavage (BAL) fluid and
sputum of patients with GOR (and co-existent respiratory conditions) at concentrations ranging from 0.4 μM up to 32
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μM [24, 25]. A predisposition to pulmonary infection has been associated with Bile Acid (BA) aspiration in several
studies [25 - 29], including infection with Pseudomonas aeruginosa, an important pathogen associated with several
respiratory diseases. This is particularly relevant in the CF patient population, as the presence of pseudomonas in the CF
airway is associated with increased morbidity and mortality [30, 31]. Bile acid aspiration has been linked with airways
inflammation, with a correlation between alveolar neutrophils and interleukin-8 (IL-8) with BAL fluid BAs described in
post- lung transplant and cystic fibrosis populations [25, 26, 29].
Bile acid aspiration has also been associated with increased BAL tumor necrosis factor alpha (TNF-α) in a rodent
model  of  chronic  aspiration,  leading  to  downstream  pro-inflammatory  cascade  [34].  However,  the  definitive
mechanisms underpinning the impact of BA aspiration on lung inflammation and infection remain poorly elucidated. It
is possible that the presence of BAs in the airways may trigger host factors, such as transcription factors, which in turn
may modulate  the  ensuing  immune  response  pathways.  One  potential  target  is  hypoxia-inducible  factor  1  (HIF-1).
HIF-1  has  been  characterized  to  be  an  emerging  master  regulator  in  the  host  response  to  infection  [32  -  35]  and
inflammation  [36].  HIF-1  induces  genes  involved in  the  host  immune response,  such  as  nitric  oxide,  antimicrobial
peptides,  and  several  cytokines,  including  TNF-α,  which  have  been  demonstrated  to  play  an  important  role  in
containing  infection  [37].  Legendre  et  al.  proposed  that  the  suppression  of  HIF-1  signaling  by  BAs  may  have  a
significant influence on the progression and outcome of respiratory disease. They further found that the effects of BAs
on cytokine production could at least as important as bacterium-mediated responses [38].
The inflammatory cascade that results from direct caustic action of pH and the exposure to acidic gastric aspirate
has been well established but what of the non-acidified gastric aspirate? There is growing evidence from animal studies
for  small  (~10mm)  non-acidified  gastric  particles  (SNAPs).  Studies  using  tracheal  instillation  of  SNAPs  in  rats
demonstrated an acute neutrophilic inflammatory response at 4-6 hours. The initial oedema seen in previous studies
using the aspiration of dilute hydrochloric acid (HCL) to form an animal model, was however not seen [39]. Acute
inflammatory markers including TNF-α, CXCL2 and CINC-1 were found to be elevated in the BAL from rats [40, 41].
It has been postulated that the presence of Monocyte Chemoattractant protein-1 (MCP-1/CCL2) may be responsible for
the innate pulmonary inflammatory response and the development of granuloma. CCL2 is produced by numerous cells
including vascular endothelial cells and alveolar type II pneumocytes. Mounting evidence suggests that CCL2 and its
haematopoietic cell receptor CC Chemokine Receptor 2 (CCR2) are involved in inflammatory disorders of the lung. In
animal models of allergic asthma, idiopathic pulmonary fibrosis (IPF), and bronchiolitis obliterans syndrome (BOS),
CCL2  expression  and  protein  production  are  increased  and  the  disease  process  is  attenuated  by  CCL2  immuno-
neutralization. Postulated mechanisms of action include recruitment of regulatory and effector leukocytes; induction of
fibroblast production of transforming growth factor-β (TGF-β) and pro-collagen; stimulation of histamine or leukotriene
release from mast cells or basophils; and enhancement of Th2 polarization [42].
In truth, the severity of injury associated with gastric aspiration is as a result of a combination of the two insults,
both acid and SNAP. In both rat and murine models, the severity of lung injury from a combined injury is more severe
than for either SNAP or as a result of acid exposure alone [40, 43, 44]. Levels of albumin in BAL, which when raised,
is associated with the loss of membrane integrity, are significantly higher in those rats exposed to the dual insult. There
is in fact an observed synergistic response that may account for the increased severity of lung injury observed, one that
is  far  greater  than  injury  levels  occurring  with  individual  component  injuries  alone.  Neutrophils  (numbers)  are
dramatically increased in rodent BAL who have been subjected to a dual insult compared to acid or SNAP alone. These
levels remain high 48 hours post aspiration, indicating leukocytic infiltration [40]. Levels of CINC-1 (rat homologue of
IL-8), IL-10, CCL2 were also elevated in those exposed to dual insult compared to ACID or SNAP alone. In this model,
IL-10 levels were the single best predictor of lung injury severity [40]. This finding is consistent with the interpretation
that increases in this anti-inflammatory (down-modulatory) cytokine are important in protective responses against acute
inflammation. Treatment with IL-10 reduces the influx of inflammatory cells and suppressed the expression of IL-6,
TNFα and CXCL2. Upon exposure, NF-κB activation is one of the first pulmonary responses, and it occurs before the
detection of any increase in pro-inflammatory cytokines [45]. Nuclear factor-κB controls the expression of some 200
target genes, many of which are involved in inflammation, such as adhesion molecules, interleukins, chemokines, acute
phase response genes and cytokines [46].  In Li.  et  al’s  study,  treatment  with exogenous IL-10 reduced NF-κB p65
expression, which might mediate the suppressive action of IL-10 on the formation of these pro-inflammatory cytokines
and subsequent inflammation [47].
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Fig.  (1).  Gastric  aspiration  and  the  complex  inflammatory  cascade  in  airway  epithelium  and  endothelium.  Direct  and  indirect
pathways when exposed to acid environment as well as the parallel pathways involving pepsin and bile salts, ultimately leading to
endothelial damage, and acute and chronic lung injury. TNF- α (Tumour necrosis factor-α), IL-8 (Interleukin-8), MIP-2 (macrophage
inflammatory  protein),  CINC2  (Cytokine-induced  neutrophil  chemoattractant),  MCP  (Monocyte  chemotactic  protein),  CCL2
(chemokine (C-C motif) ligand), TGF-β (Transforming growth factor), NADPH (Nicotinamide adenine dinucleotide phosphate), and
NFR-2 (Nuclear factor (erythroid-derived 2)-like 2).
3. ACUTE LUNG INJURY
Inflammation related to aspiration and reflux not only plays an important role in chronic respiratory diseases such as
asthma,  COPD,  IPF,  Cystic  Fibrosis,  and  in  the  post  lung  transplant  population,  it  is  also  apparent  that  it  plays  a
significant  role  in  acute  respiratory  illness.  Aspiration-induced lung injury  often  goes  unrecognized  in  critically  ill
patients and it  is  postulated that  it  may account for a significant proportion of acute pulmonary dysfunction in this
setting [39]. Despite this, aspiration is well recognized as an independent risk factor for the subsequent development of
pneumonia or acute lung injury or acute respiratory distress syndrome (ALI/ARDS) [48]. The underlying mechanisms
responsible  for  the  progression  to  severe  pulmonary  inflammation  with  ensuing  ALI/ARDS  as  a  result  of  gastric
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aspiration are not fully understood. In a prospective study of critically ill patients, Metheny and colleagues found that in
patients who were ventilated and tube fed for a minimum of 4 days that at least one aspiration event occurred in almost
90% of the patients [49]. The degree of lung injury as a consequence of gastric aspiration ranges from mild pneumonitis
to severe, progressive respiratory failure with an associated significant detrimental impact on patient outcome. It has
been recognized therefore that gastric aspiration may directly cause ALI and the more severe clinical phenotype, ARDS
[39,  50,  52].  The clinical  development  of  ALI/ARDS typically  involves  a  sudden,  severe  pulmonary inflammatory
injury with the loss of integrity of alveolar-capillary permeability. Hence, this injury may result in alveolar edema, loss
of lung compliance, hypoxemia, and frequently is associated with multi-organ system failure [39, 42]. The economic
and healthcare impact of ALI/ARDS is significant, with economic costs of 3.5 – 6 billion dollars and mortality levels of
30-40% reported in the United States [53, 54]. Furthermore, aspiration pneumonitis and ensuing ALI/ARDS is believed
to account for up to 20% of all deaths attributable to anesthesia [55 - 57].
Animal  experimental  models  of  the  acid component  of  gastric  aspirates  are  frequently  created by intra-tracheal
instillation  of  HCL.  Following  aspiration  of  dilute  HCL,  lung  injury  in  adult  rats  is  characterized  by  a  biphasic
response. The early phase insult is mediated by stimulation of capsaicin sensitive neurons as well as the direct caustic
actions of low pH on airway epithelium, and is followed by an acute neutrophilic inflammatory response at 4-6 hours
[58].  The combination of  these  mechanisms leads  to  the  loss  of  microvascular  integrity,  extravasation of  fluid  and
protein into the airways and alveoli. The presence of fluid secondary to oedema may reduce airway compliance while
the plasma proteins in the oedema fluid can directly interfere with alveolar surfactant function. Aspiration of low pH
gastric  contents  is  characterized  by  a  neutrophilic  airway  influx.  Levels  of  TNF–α  and  concentrations  of  several
important chemotactic cytokines (chemokines) in BAL have also been found to be elevated following gastric aspiration
[59, 60] Fig. (1). This includes elevated levels of the neutrophil chemotactic chemokine IL-8 in rabbits, or CXCL2 and
cytokine  induced  neutrophil  chemoattractant–1  (CINC-1)  in  rodents,  during  acid  induced  lung  injury  [40,  41,  61].
Levels of leukocyte derived oxidants and proteinases, including elastase have similarly been shown to be increased in
acid-induced lung injury [62, 63]. Activation of complement is also described as important in the systemic response and
the consequent injury that occurs following gastric aspiration [64].
Recruitment  of  neutrophils  and  release  of  reactive  oxygen  species  are  considered  to  be  major  pathogenic
components  driving  ALI.  However,  NADPH  oxidase,  the  major  source  of  reactive  oxygen  species  in  activated
phagocytes, can paradoxically limit inflammation and injury. NADPH oxidase generates the oxidative “burst” in PMNs,
leading to the production of ROS (reactive oxygen species) and activation and release of PMN granular proteases [65 -
68] In addition to this enzyme’s critical host defense function, NADPH oxidase also regulates inflammation. In studies
of  lung  inflammation  induced  by  microbial-derived  products,  NADPH  oxidase  restrained  lung  inflammation  by
activation of Nrf2, a redox-sensitive anti-oxidative and anti-inflammatory transcription factor [66].  Experiments by
Davidson et al. in mice models of ALI showed that NADPH oxidase activation leads to rapid generation of ROS and
activation of PMN granular proteases responsible for killing invading pathogens [69]. While initial actions are clearly
injurious, the study demonstrated that NADPH oxidase could also counterbalance these early pro-inflammatory and
injurious events.
4. ANTI-INFLAMMATORY TREATMENT
Our knowledge of the pathogenesis of reflux mediated cell injury has exponentially expanded over the last number
of years. However, despite an improved understanding of the mechanisms involved, this has not led to any new forms
of treatment. Despite the acknowledgement that pepsin, bile salts, acidic and non-acidic reflux play interchangeable
roles  in  the  end  pathology  of  aspiration,  treatment  options  are  still  restricted  to  proton  pump  inhibitors  (PPI)  and
surgical intervention, both of which have yielded mixed results. Understanding of the role played by PPIs comes from
studies  looking  at  their  effect  on  acidic  bile  salts.  Huo  et  al.  demonstrated  the  omeprazole  inhibits  IL-8  secretion
stimulated by exposure to acid and bile salts from esophageal epithelial cell [70]. They demonstrated that acidic bile
salts activate the IL-8 promoter through nuclear factor (NF)- κB and activator protein (AP)-1 DNA binding sites, and
that the omeprazole inhibits IL-8 production by blocking nuclear translocation of p65, as well as decreased binding of
p65,  c-jun  and  c-fos  to  the  IL-8  promoter.  These  effects  were  independent  of  the  effects  on  gastric  acid  secretion
demonstrating  a  novel  mechanism that  might  contribute  to  the  beneficial  effects  of  PPIs  in  the  treatment  of  reflux
related pulmonary inflammation. The caveat to this finding comes in research by Pauwels et al. examining the effect of
aspirate of CF patients being treated with a PPI, that showed a significantly enhanced inflammatory effect (higher IL-8
production) on CF bronchial epithelial cells in culture. As chronic PPI treatment in CF may result in a paradoxically
increased  inflammatory  effect  in  the  airways,  alternative  anti-reflux  therapies  should  be  considered  in  CF.  If
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uncontrolled  GORD  is  present  and  medical  management  fails,  fundoplication  may  have  a  role  in  preserving  lung
function and improving pulmonary status in a small, carefully selected patient group [71]. Interleukin-6 is one of the
key mediators of fibrosis in chronic inflammation in animal models, and it may be that better understanding of these
critical elements within the inflammatory cascade may yield pharmacogenic therapies in the years to come.
CONCLUSION
Available clinical and experimental evidence points to a possible relationship between the progression of airways
disease, pro-inflammatory processes and gastric aspiration. In order to progress this further it is now critical to initiate
development and implementation of pharmacological or surgical interventions in the relevant patient groups, targeted at
reducing gastric aspiration rates with objective measures of airways disease as the primary outcomes in adequately
powered, controlled studies. Such studies will ultimately allow us to determine whether any causal relationship between
aspiration and severity of airways disease does indeed exist.
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